Cargando…

Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry

BACKGROUND: Over the last 50 years, the epidemiology of hypertrophic cardiomyopathy (HCM) has changed because of increased awareness and availability of advanced diagnostic tools. We aim to describe the temporal trends in age, sex, and clinical characteristics at HCM diagnosis over >4 decades. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Canepa, Marco, Fumagalli, Carlo, Tini, Giacomo, Vincent-Tompkins, Justin, Day, Sharlene M., Ashley, Euan A., Mazzarotto, Francesco, Ware, James S., Michels, Michelle, Jacoby, Daniel, Ho, Carolyn Y., Olivotto, Iacopo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497482/ https://www.ncbi.nlm.nih.gov/pubmed/32894986 http://dx.doi.org/10.1161/CIRCHEARTFAILURE.120.007230

Ejemplares similares

Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)
por: Ho, Carolyn Y., et al.
Publicado: (2018)

Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction: Insights From the SHaRe Registry
por: Marstrand, Peter, et al.
Publicado: (2020)

Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy
por: Marston, Nicholas A, et al.
Publicado: (2021)

Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy
por: Toepfer, Christopher N., et al.
Publicado: (2020)

Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretation
por: Thompson, Andrea D., et al.
Publicado: (2021)

Spatial and Functional Distribution of MYBPC3 Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy
por: Helms, Adam S., et al.
Publicado: (2020)

Clinical Phenotype and Outcome of Hypertrophic Cardiomyopathy Associated With Thin-Filament Gene Mutations
por: Coppini, Raffaele, et al.
Publicado: (2014)

Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy
por: Walsh, Roddy, et al.
Publicado: (2019)

INHERIT (INHibition of the renin angiotensin system in hypertrophic cardiomyopathy and the Effect on hypertrophy—a Randomised Intervention Trial with losartan)
por: Olivotto, Iacopo, et al.
Publicado: (2015)

Myocardial Deformation Analysis in MYBPC3 and MYH7 Related Sarcomeric Hypertrophic Cardiomyopathy—The Graz Hypertrophic Cardiomyopathy Registry
por: Höller, Viktoria, et al.
Publicado: (2021)

Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry
por: Abou Alaiwi, Sarah, et al.
Publicado: (2023)

Microvascular Dysfunction in Hypertrophic Cardiomyopathy
por: Pelliccia, Francesco, et al.
Publicado: (2022)

Comparative analysis of right ventricular strain in Fabry cardiomyopathy and sarcomeric hypertrophic cardiomyopathy
por: Meucci, Maria Chiara, et al.
Publicado: (2022)

Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers
por: Lorenzini, Massimiliano, et al.
Publicado: (2020)

Pathogenic Mechanisms of Hypertrophic Cardiomyopathy beyond Sarcomere Dysfunction
por: Chou, Chun, et al.
Publicado: (2021)

Childhood Hypertrophic Cardiomyopathy: A Disease of the Cardiac Sarcomere
por: Norrish, Gabrielle, et al.
Publicado: (2021)

Impact of Demographic Features, Lifestyle, and Comorbidities on the Clinical Expression of Hypertrophic Cardiomyopathy
por: Finocchiaro, Gherardo, et al.
Publicado: (2017)

Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing?
por: Mazzarotto, Francesco, et al.
Publicado: (2020)

Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy
por: Farhad, Hoshang, et al.
Publicado: (2017)

Sex-Related Differences in Protein Expression in Sarcomere Mutation-Positive Hypertrophic Cardiomyopathy
por: Schuldt, Maike, et al.
Publicado: (2021)

Sarcomere mutation negative hypertrophic cardiomyopathy is associated with ageing and obesity
por: de Feria, Alejandro E, et al.
Publicado: (2021)

Multimodality Imaging in Sarcomeric Hypertrophic Cardiomyopathy: Get It Right…on Time
por: Galluzzo, Alessandro, et al.
Publicado: (2023)

Hypertrophic cardiomyopathy: The need for randomized trials
por: Olivotto, Iacopo, et al.
Publicado: (2013)

Diagnostic and prognostic electrocardiographic features in patients with hypertrophic cardiomyopathy
por: Bernardini, Andrea, et al.
Publicado: (2023)

Impact of SARS‐Cov‐2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry
por: Gimeno, Juan R., et al.
Publicado: (2022)

Genetic profile of hypertrophic cardiomyopathy in Tunisia: Is it different?
por: Jaafar, Nawel, et al.
Publicado: (2015)

Stage-specific therapy for hypertrophic cardiomyopathy
por: Argirò, Alessia, et al.
Publicado: (2023)

Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes
por: Walsh, Roddy, et al.
Publicado: (2017)

A Contraction Stress Model of Hypertrophic Cardiomyopathy due to Sarcomere Mutations
por: Cohn, Rachel, et al.
Publicado: (2018)

Disruption of embryonic ROCK signaling reproduces the sarcomeric phenotype of hypertrophic cardiomyopathy
por: Bailey, Kate E., et al.
Publicado: (2019)

Disruption of embryonic ROCK signaling reproduces the sarcomeric phenotype of hypertrophic cardiomyopathy
por: Bailey, Kate E., et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy in Children: Pathophysiology, Diagnosis, and Treatment of Non-sarcomeric Causes
por: Monda, Emanuele, et al.
Publicado: (2021)

Microstructural and Microvascular Phenotype of Sarcomere Mutation Carriers and Overt Hypertrophic Cardiomyopathy
por: Joy, George, et al.
Publicado: (2023)

Prediction and visualization data for the interpretation of sarcomeric and non-sarcomeric DNA variants found in patients with hypertrophic cardiomyopathy
por: Bottillo, Irene, et al.
Publicado: (2016)

Prognostic significance of left atrial strain in sarcomere gene variant carriers without hypertrophic cardiomyopathy
por: Huurman, Roy, et al.
Publicado: (2022)

Genomic Context Differs Between Human Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
por: Puckelwartz, Megan J., et al.
Publicado: (2021)

Old and new therapeutic solutions in the treatment of hypertrophic cardiomyopathy
por: Autore, Camillo, et al.
Publicado: (2023)

Emerging Medical Treatment for Hypertrophic Cardiomyopathy
por: Argirò, Alessia, et al.
Publicado: (2021)

Novel Morphological Features on CMR for the Prediction of Pathogenic Sarcomere Gene Variants in Subjects Without Hypertrophic Cardiomyopathy
por: van der Velde, Nikki, et al.
Publicado: (2021)

Preclinical alterations in cardiac energetics amongst sarcomere mutation carriers in hypertrophic cardiomyopathy
por: Lloyd, Rachael, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jlmadirdkor3oefc0fjidpb948